Syneos Health Toekomstige groei

Future criteriumcontroles 3/6

Syneos Health zal naar verwachting groeien in winst en omzet met respectievelijk 33.7% en 1.4% per jaar. De winst per aandeel zal naar verwachting groeien met 40.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.7% zijn.

Belangrijke informatie

33.7%

Groei van de winst

n/a

Groei van de winst per aandeel

Life Sciences winstgroei18.4%
Inkomstengroei1.4%
Toekomstig rendement op eigen vermogen9.7%
Dekking van analisten

Good

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Recent updates

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 29
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Mar 10
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Feb 20
Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Dec 20
Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Nov 28
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Nov 01
Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Syneos, Datavant expand partnership on data analytics for clinical trials

Oct 11

Syneos Health falls 13% after update on outlook

Sep 13

When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Sep 08
When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Aug 22
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Syneos Health Q2 2022 Earnings Preview

Aug 01

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Jul 19
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Syneos: Upside Could Be Priced In, Valuations Unsupportive

Jul 15

Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Jun 18
Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Jun 03
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

May 19
We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Apr 08
Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors

Mar 27

Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 05
Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Feb 18
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

Feb 03
Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Jan 04
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022

Dec 03

Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Dec 03
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Winst- en omzetgroeiprognoses

NasdaqGS:SYNH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20255,4782674674637
12/31/20245,2502204634517
12/31/20235,146433364388
6/30/20235,41971162253N/A
3/31/20235,414148289387N/A
12/31/20225,393266334427N/A
9/30/20225,407287392489N/A
6/30/20225,419278323405N/A
3/31/20225,340242325394N/A
12/31/20215,213235393450N/A
9/30/20214,980251337379N/A
6/30/20214,730236444486N/A
3/31/20214,461198542591N/A
12/31/20204,416193375425N/A
9/30/20204,489192420472N/A
6/30/20204,567187324390N/A
3/31/20204,720195229293N/A
12/31/20194,676131255318N/A
9/30/20194,60886208270N/A
6/30/20194,54617272322N/A
3/31/20194,45219292337N/A
12/31/20184,39024249303N/A
9/30/20183,995-36221280N/A
6/30/20183,472-174104165N/A
3/31/20182,658-1842176N/A
12/31/20171,853-138154198N/A
9/30/20171,365-8681124N/A
6/30/20171,03389128163N/A
3/31/20171,033116N/A186N/A
12/31/20161,030113N/A109N/A
9/30/20161,009106N/A159N/A
6/30/2016984116N/A154N/A
3/31/2016952109N/A160N/A
12/31/2015915117N/A205N/A
9/30/201588733N/A155N/A
6/30/20158608N/A146N/A
3/31/20158370N/A144N/A
12/31/2014810-27N/A131N/A
9/30/201477013N/A142N/A
6/30/2014732-1N/A121N/A
3/31/2014687-27N/A86N/A
12/31/2013652-42N/A37N/A
12/31/2012579-60N/A43N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei SYNH ( 33.7% per jaar) ligt boven de spaarquote ( 2.2% ).

Winst versus markt: De winst van SYNH ( 33.7% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).

Hoge groeiwinsten: De winst van SYNH zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van SYNH ( 1.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van SYNH ( 1.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen SYNH zal naar verwachting over 3 jaar laag zijn ( 9.7 %).


Ontdek groeibedrijven